Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

CardioMEMS HF System

Remote Pulmonary Pressure Monitoring

CardioMEMS HF System
Patient Selection

CardioMEMS Patient Selection & Assessment

Selecting the Right Patient for Remote PA Pressure Monitoring

The CardioMEMS™ HF System is indicated for patients with:

  • NYHA Class II or Class III heart failure; and
  • Hospitalized for heart failure in the previous year; and/or
  • Elevated natriuretic peptides

 

The CardioMEMS HF System is contraindicated for patients with:

  • An inability to take dual antiplatelet or anticoagulants for one month post-implant
     

Is your patient indicated for CardioMEMS HF System?

Answer questions to help you determine if your heart failure patient is indicated for the CardioMEMS HF System.

Indication criteria for this quiz is based on the CardioMEMS HF System instructions for use. This quiz is not intended to replace professional expertise or information. Patient selection is always at the discretion of the care team and dependent on each patient's unique condition. Abbott is a medical device manufacturer and cannot provide medical advice.
 

CardioMEMS HF System Indication Quiz

  • NYHA Class
  • Hospitalization
  • BNP
  • Threshold Data
 

What NYHA Class of Heart Failure does the patient have?

NYHA Classes of Heart Failure

Class I: No symptoms of heart failure, and no limitations on physical activity

Class II: Symptoms of heart failure with moderate exertion, such as walking two blocks or up two flights of stairs

Class III: Symptoms of heart failure with minimal exertion, such as walking one block or up one flight of stairs, but no symptoms at rest

Class IV: Inability to carry on any physical activity without discomfort, and symptoms of congestive heart failure even at rest

 
Modal
Modal
Modal
Modal
 

Has the patient had at least one HF hospitalization in the past 12 months?

 
 

Do you know the patient's BNP or NT-proBNP level?

 

Enter either the patient's most recent NT-proBNP or BNP value

 
 

Enter BMI and Ejection Fraction

BMI and Ejection Fraction needed to determine indication

Round down to nearest value

CardioMEMS HF System: Covered by Medicare Advantage

The CardioMEMS HF System Coverage with Evidence Development (CED) study is now approved by the Centers for Medicare and Medicaid Services (CMS) for the implantable pulmonary artery pressure sensors (IPAPS) National Coverage Determination (NCD). This means all Medicare beneficiaries, including previously denied Medicare Advantage patients, will have access to the CardioMEMS HF System when policy criteria of NCD is met.

See NCD Information

CardioMEMS PA Pressure Monitoring Resources

This document provides information to select heart failure patients who would benefit most from the CardioMEMS HF System, along with BNP thresholds.

Download Patient Considerations Tool
CardioMEMS PA pressure monitoring selection resources

Patients who most commonly receive the CardioMEMS HF System are those on GDMT and those who exhibit any of the following:2

  • Fluid volumes that are hard to know or manage
  • Challenging physical assessment
  • Is a patient with HFpEF or HFrEF
  • Compliant with heart failure medical care
  • Would benefit from remote monitoring if they live far from a clinic

NYHA Classes of Heart Failure

Stages of Heart Failure

Receive case studies of patients living with the CardioMEMS HF System

Sign Up
Reimbursement & Coding

Reimbursement & Coding

Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

References

  1. Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M., Costanzo, M. R., Stevenson, L. W., …Yadav, J. S., for the CHAMPION Trial Study Group. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. The Lancet, 377(9766), 658-666. https://dx.doi.org/10.1016/S0140-6736(11)60101-3

MAT-2006770 v12.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-1900882 v14.0